Change search criteria ↓

Search results

533 projects found matching your search criteria:

  1. 151. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t…

    Principal investigator: dr Jan Marian Suski

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 14, Panel: NZ3

  2. 152. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 27, Panel: NZ5

  3. 153. Decoding novel O/K loci of Klebsiella pneumoniae into chemical O/K antigen structures – towards better adjustment of bac…

    Principal investigator: prof. Jolanta Katarzyna Łukasiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 27, Panel: NZ7

  4. 154. Phage Therapy Antipersister Strategy

    Principal investigator: prof. Zuzanna Drulis-Kawa

    Uniwersytet Wrocławski

    Call: JPIAMR ACTION Call 2024, Panel: NZ6

  5. 155. Genetic background of chromothripsis, its role in clonal evolution and response to therapy in childhood acute lymphoblas…

    Principal investigator: dr hab. Agata Karolina Pastorczak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 27, Panel: NZ5

  6. 156. Longitudinal analysis of changes in the expression, activity, and regulation mechanisms of the NLRP3 inflammasome in mon…

    Principal investigator: prof. Joanna Saluk

    Uniwersytet Łódzki

    Call: OPUS 27, Panel: NZ7

  7. 157. Assessment of the potential of new histidine hybrids and simulation of their metabolism as a potential therapy for neuro…

    Principal investigator: prof. Paweł Bartosz Szymański

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 27, Panel: NZ7

  8. 158. Comprehensive structural and functional analysis of p53 mRNA to identify secondary and tertiary RNA structures important…

    Principal investigator: dr Leszek Michał Błaszczyk

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 27, Panel: NZ5

  9. 159. Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

    Principal investigator: dr Karolina Kinga Zajdel

    Narodowe Centrum Badań Jądrowych

    Call: SONATINA 8, Panel: ST5

  10. 160. Nature-inspired conductive and bioadhesive kirigami-based nanoarchitectured cardiac patch for combined chemo- and stem c…

    Principal investigator: dr hab. Filippo Pierini

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

    Call: OPUS 26, Panel: ST5

  11. 161. Platelet-derived growth factor (PDGF-BB) and its peptide derivative as factors increasing cell activity for use in diabe…

    Principal investigator: dr Milena Deptuła

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 19, Panel: NZ3

  12. 162. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 26, Panel: NZ7

  13. 163. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect…

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 26, Panel: NZ7

  14. 164. "One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes…

    Principal investigator: dr Barbara Ewa Pucelik

    Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

    Call: SONATA 19, Panel: NZ7

  15. 165. Mitochondrial targets of flozins in endothelial cells - a new approach to the prevention, diagnosis and therapy of heart…

    Principal investigator: dr hab. Barbara Anna Kutryb-Zając

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 26, Panel: NZ4

  16. 166. Bacterial membrane carriers targeting tumor-associated microbes for advanced cancer therapy

    Principal investigator: dr Monika Kluzek

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: OPUS 26, Panel: NZ7

  17. 167. Cannabidiol as a modulator of radiological response in the therapy of peripheral nervous system tumors - lipidomics from…

    Principal investigator: dr Karolina Anna Chrabąszcz

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

    Call: SONATA 19, Panel: ST4

  18. 168. The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi…

    Principal investigator: dr hab. Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM BIS 5, Panel: NZ7

  19. 169. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: OPUS 25, Panel: ST4

  20. 170. Biomaterials inducing DNA demethylation as tools for future neuron regeneration therapies

    Principal investigator: dr hab. Katarzyna Nawrotek

    Politechnika Warszawska

    Call: OPUS 25, Panel: ST8

  21. 171. Endothelial bioenergetics as a novel target for vascular protection – unveiling the mitochondrial mechanisms of lipid-lo…

    Principal investigator: dr Alicja Małgorzata Braczko

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ5

  22. 172. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 25, Panel: NZ6

  23. 173. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

    Principal investigator: dr hab. Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 18, Panel: NZ3

  24. 174. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

    Principal investigator: prof. Rafał Artur Bartoszewski

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 24, Panel: NZ7

  25. 175. Energy storing particles for recharged luminescence bio-tracking and therapy

    Principal investigator: dr hab. Dominika Michalina Wawrzyńczyk

    Politechnika Wrocławska

    Call: OPUS 24, Panel: ST5

  26. 176. Bisphosphonate complexes based on103Pd/103mRh in vivo generator for Auger electron therapy of bone cancer metastases

    Principal investigator: prof. Aleksander Józef Bilewicz

    Instytut Chemii i Techniki Jądrowej

    Call: OPUS 23, Panel: ST4

  27. 177. Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies…

    Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 23, Panel: NZ7

  28. 178. Modulation of HIV-1 epitranscriptome: A novel approach to improve "shock & kill" therapy.

    Principal investigator: Haider Ali brak danych (PI has only a Name - in accordance with PESEL)

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 21, Panel: NZ6

  29. 179. Anti-inflammatory effect of senotherapeutic agents on gingival fibroblasts as a potential therapy for periodontitis

    Principal investigator: Alicja Danuta Płonczyńska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 21, Panel: NZ5

  30. 180. Photoactivated gold nanoparticles as promising agents for photothermal therapy – in vitro studies in biomimetic membrane…

    Principal investigator: Beata Tim

    Politechnika Poznańska, Wydział Inżynierii Materiałowej i Fizyki Technicznej

    Call: PRELUDIUM 21, Panel: ST5

  31. 181. Interventions against polarisation in society for Trustworthy social media: From diagnosis to therapy

    Principal investigator: dr hab. Katarzyna Budzyńska

    Politechnika Warszawska, Wydział Administracji i Nauk Społecznych

    Call: CHIST-ERA2021, Panel: ST6

  32. 182. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  33. 183. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the…

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: PRELUDIUM BIS 3, Panel: NZ5

  34. 184. Treating procrastination - effectiveness and neurobehavioral mechanisms of Cognitive-Behavioral Therapy and Working Time…

    Principal investigator: dr Marek Piotr Wypych

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 22, Panel: HS6

  35. 185. The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients

    Principal investigator: prof. Krzysztof Georgios Giannopoulos

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

    Call: PRELUDIUM BIS 3, Panel: NZ5

  36. 186. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a…

    Principal investigator: dr hab. Dorota Justyna Łażewska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  37. 187. Species belonging to lichens and bryophytes as a useful source of biologically active compounds in therapy of skin disea…

    Principal investigator: prof. Sławomir Daniel Dresler

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM BIS 3, Panel: NZ7

  38. 188. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of…

    Principal investigator: dr hab. Carlo Vascotto

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: OPUS 22, Panel: NZ5

  39. 189. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  40. 190. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ5

  41. 191. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy…

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 3, Panel: NZ7

  42. 192. Monitoring and pharmacokinetics of midazolam by patients with COVID-19 receiving respirator and ECMO therapy.

    Principal investigator: dr Marek Arnold Grochla

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Zabrzu

    Call: PRELUDIUM 20, Panel: NZ6

  43. 193. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized…

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  44. 194. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  45. 195. Breast cancer metastasis-induced endothelial-mesenchymal transition alongside ageing; implications for therapy

    Principal investigator: dr hab. Marta Maria Smęda

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: OPUS 21, Panel: NZ5

  46. 196. Normalization of energy metabolism as a way to develop innovative antithrombotic therapies

    Principal investigator: dr Patrycja Kaczara

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: OPUS 21, Panel: NZ7

  47. 197. Addressing the brain glioma temozolomide therapy limitations

    Principal investigator: dr hab. Joanna Małgorzata Lewandowska-Łańcucka

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 21, Panel: NZ7

  48. 198. Mechanisms involved in heme acquisition - potential targets for therapies directed towards reduction of Porphyromonas gi…

    Principal investigator: dr Michał Sylwester Śmiga

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 21, Panel: NZ6

  49. 199. MLK4 signaling in DNA damage response and cancer therapy

    Principal investigator: Dawid Grzegorz Mehlich

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: PRELUDIUM 20, Panel: NZ3

  50. 200. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski